Literature DB >> 19447366

Is photodynamic therapy a good alternative to surgery and radiotherapy in the treatment of head and neck cancer?

Heike J Nyst1, I Bing Tan, Fiona A Stewart, Alfons J M Balm.   

Abstract

The mainstay treatments for head and neck carcinomas are surgery, radiotherapy and chemotherapy. These treatment options may be associated with considerable complications. Radical radiotherapy and chemotherapy can generally be employed only once, which presents difficulties in cases of recurrent disease or second primaries within the irradiated field. Salvage surgery at the same site is often difficult, due to progressive tissue loss. In this respect photodynamic therapy (PDT) seems to be a good alternative treatment option for small, localized tumors; with a good outcome and with excellent functional and cosmetic results. Selected patients with advanced cancer of the head and neck, who have exhausted other treatment options, can also achieve improvement in quality of life with PDT. The advantages of PDT compared with surgery or radiotherapy are reduced long-term morbidity and the fact that PDT does not compromise future treatment options for recurrent, residual or second primary disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19447366     DOI: 10.1016/j.pdpdt.2009.03.002

Source DB:  PubMed          Journal:  Photodiagnosis Photodyn Ther        ISSN: 1572-1000            Impact factor:   3.631


  15 in total

1.  Image-guided Interstitial Photodynamic Therapy for Squamous Cell Carcinomas: Preclinical investigation.

Authors:  Mirabelle Sajisevi; Nestor R Rigual; David A Bellnier; Mukund Seshadri
Journal:  J Oral Maxillofac Surg Med Pathol       Date:  2015-03

2.  Photocytotoxic trans-diam(m)ine platinum(IV) diazido complexes more potent than their cis isomers.

Authors:  Nicola J Farrer; Julie A Woods; Vivienne P Munk; Fiona S Mackay; Peter J Sadler
Journal:  Chem Res Toxicol       Date:  2010-02-15       Impact factor: 3.739

3.  Type 1 Phototherapeutic Agents. 2. Cancer Cell Viability and ESR Studies of Tricyclic Diarylamines.

Authors:  Raghavan Rajagopalan; Tien-Sung Lin; Amolkumar S Karwa; Amruta R Poreddy; Bethel Asmelash; Richard B Dorshow
Journal:  ACS Med Chem Lett       Date:  2012-02-16       Impact factor: 4.345

4.  Explicit dosimetry for photodynamic therapy: macroscopic singlet oxygen modeling.

Authors:  Ken Kang-Hsin Wang; Jarod C Finlay; Theresa M Busch; Stephen M Hahn; Timothy C Zhu
Journal:  J Biophotonics       Date:  2010-06       Impact factor: 3.207

Review 5.  Contemporary management of cancer of the oral cavity.

Authors:  Eric M Genden; Alfio Ferlito; Carl E Silver; Robert P Takes; Carlos Suárez; Randall P Owen; Missak Haigentz; Sandro J Stoeckli; Ashok R Shaha; Alexander D Rapidis; Juan Pablo Rodrigo; Alessandra Rinaldo
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-02-13       Impact factor: 2.503

6.  TP53 regulates human AlkB homologue 2 expression in glioma resistance to Photofrin-mediated photodynamic therapy.

Authors:  S Y Lee; S K Luk; C P Chuang; S P Yip; S S T To; Y M B Yung
Journal:  Br J Cancer       Date:  2010-07-27       Impact factor: 7.640

7.  Biodistribution Study of Nanoparticle Encapsulated Photodynamic Therapy Drugs Using Multispectral Imaging.

Authors:  Luma V Halig; Dongsheng Wang; Andrew Y Wang; Zhuo Georgia Chen; Baowei Fei
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2013-03-29

8.  Photodynamic therapy with 3-(1'-hexyloxyethyl) pyropheophorbide a for cancer of the oral cavity.

Authors:  Nestor Rigual; Gal Shafirstein; Michele T Cooper; Heinz Baumann; David A Bellnier; Ulas Sunar; Erin C Tracy; Daniel J Rohrbach; Gregory Wilding; Wei Tan; Maureen Sullivan; Mihai Merzianu; Barbara W Henderson
Journal:  Clin Cancer Res       Date:  2013-10-02       Impact factor: 12.531

9.  A matched cohort comparison of mTHPC-mediated photodynamic therapy and trans-oral surgery of early stage oral cavity squamous cell cancer.

Authors:  Baris Karakullukcu; Sharon D Stoker; Anne P E Wildeman; Marcel P Copper; Maarten A Wildeman; I Bing Tan
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-07-07       Impact factor: 2.503

Review 10.  Clinical development and potential of photothermal and photodynamic therapies for cancer.

Authors:  Xingshu Li; Jonathan F Lovell; Juyoung Yoon; Xiaoyuan Chen
Journal:  Nat Rev Clin Oncol       Date:  2020-07-22       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.